住友ファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/28 | 1,993 | 2,007 | 1,980 | 2,002 | -21 | -1% | 1,145,100 |
2020/01/27 | 2,049 | 2,060 | 2,009 | 2,023 | -57 | -2.7% | 753,700 |
2020/01/24 | 2,111 | 2,114 | 2,078 | 2,080 | -29 | -1.4% | 659,500 |
2020/01/23 | 2,130 | 2,133 | 2,105 | 2,109 | -43 | -2% | 607,800 |
2020/01/22 | 2,165 | 2,170 | 2,149 | 2,152 | -15 | -0.7% | 599,500 |
2020/01/21 | 2,154 | 2,171 | 2,138 | 2,167 | +7 | +0.3% | 785,900 |
2020/01/20 | 2,153 | 2,162 | 2,144 | 2,160 | +3 | +0.1% | 405,300 |
2020/01/17 | 2,141 | 2,166 | 2,123 | 2,157 | +24 | +1.1% | 721,700 |
2020/01/16 | 2,168 | 2,181 | 2,129 | 2,133 | -3 | -0.1% | 835,400 |
2020/01/15 | 2,176 | 2,181 | 2,121 | 2,136 | -30 | -1.4% | 813,800 |
2020/01/14 | 2,180 | 2,191 | 2,155 | 2,166 | -9 | -0.4% | 687,400 |
2020/01/10 | 2,149 | 2,175 | 2,140 | 2,175 | +46 | +2.2% | 847,100 |
2020/01/09 | 2,111 | 2,139 | 2,104 | 2,129 | +59 | +2.9% | 805,700 |
2020/01/08 | 2,094 | 2,109 | 2,037 | 2,070 | -50 | -2.4% | 1,061,200 |
2020/01/07 | 2,095 | 2,123 | 2,088 | 2,120 | +30 | +1.4% | 889,000 |
2020/01/06 | 2,080 | 2,101 | 2,061 | 2,090 | -40 | -1.9% | 1,456,900 |
2019/12/30 | 2,149 | 2,155 | 2,124 | 2,130 | -26 | -1.2% | 560,600 |
2019/12/27 | 2,130 | 2,173 | 2,124 | 2,156 | +3 | +0.1% | 478,400 |
2019/12/26 | 2,122 | 2,157 | 2,114 | 2,153 | +20 | +0.9% | 464,200 |
2019/12/25 | 2,125 | 2,146 | 2,122 | 2,133 | +6 | +0.3% | 339,800 |
2019/12/24 | 2,140 | 2,147 | 2,117 | 2,127 | -9 | -0.4% | 506,200 |
2019/12/23 | 2,120 | 2,152 | 2,117 | 2,136 | +27 | +1.3% | 507,600 |
2019/12/20 | 2,132 | 2,138 | 2,108 | 2,109 | +4 | +0.2% | 1,210,000 |
2019/12/19 | 2,115 | 2,131 | 2,102 | 2,105 | -17 | -0.8% | 674,400 |
2019/12/18 | 2,165 | 2,170 | 2,111 | 2,122 | -54 | -2.5% | 875,800 |
2019/12/17 | 2,139 | 2,188 | 2,129 | 2,176 | +76 | +3.6% | 1,163,600 |
2019/12/16 | 2,140 | 2,142 | 2,098 | 2,100 | -70 | -3.2% | 1,430,700 |
2019/12/13 | 2,160 | 2,187 | 2,140 | 2,170 | +74 | +3.5% | 1,687,900 |
2019/12/12 | 2,160 | 2,165 | 2,096 | 2,096 | -60 | -2.8% | 795,100 |
2019/12/11 | 2,168 | 2,189 | 2,143 | 2,156 | +1 | ±0% | 993,900 |
2019/12/10 | 2,137 | 2,167 | 2,133 | 2,155 | +18 | +0.8% | 966,700 |
2019/12/09 | 2,174 | 2,178 | 2,127 | 2,137 | -48 | -2.2% | 1,044,800 |
2019/12/06 | 2,150 | 2,196 | 2,135 | 2,185 | +34 | +1.6% | 1,255,200 |
2019/12/05 | 2,110 | 2,161 | 2,103 | 2,151 | +65 | +3.1% | 1,073,900 |
2019/12/04 | 2,076 | 2,094 | 2,067 | 2,086 | -10 | -0.5% | 745,800 |
2019/12/03 | 2,080 | 2,099 | 2,060 | 2,096 | -27 | -1.3% | 1,029,900 |
2019/12/02 | 2,094 | 2,135 | 2,076 | 2,123 | +56 | +2.7% | 1,089,100 |
2019/11/29 | 2,070 | 2,094 | 2,049 | 2,067 | +20 | +1% | 979,400 |
2019/11/28 | 2,088 | 2,089 | 2,040 | 2,047 | -40 | -1.9% | 747,200 |
2019/11/27 | 2,115 | 2,125 | 2,067 | 2,087 | +16 | +0.8% | 1,653,400 |
2019/11/26 | 2,040 | 2,074 | 2,005 | 2,071 | +53 | +2.6% | 2,040,700 |
2019/11/25 | 2,075 | 2,080 | 1,991 | 2,018 | -26 | -1.3% | 1,090,400 |
2019/11/22 | 2,056 | 2,061 | 2,018 | 2,044 | -26 | -1.3% | 1,086,500 |
2019/11/21 | 2,120 | 2,124 | 2,054 | 2,070 | -70 | -3.3% | 2,359,300 |
2019/11/20 | 2,101 | 2,219 | 2,070 | 2,140 | +139 | +6.9% | 4,146,300 |
2019/11/19 | 1,895 | 2,002 | 1,893 | 2,001 | +137 | +7.3% | 2,338,500 |
2019/11/18 | 1,885 | 1,904 | 1,846 | 1,864 | +9 | +0.5% | 1,068,500 |
2019/11/15 | 1,856 | 1,871 | 1,840 | 1,855 | -3 | -0.2% | 1,025,200 |
2019/11/14 | 1,851 | 1,874 | 1,845 | 1,858 | +13 | +0.7% | 670,400 |
2019/11/13 | 1,890 | 1,890 | 1,834 | 1,845 | -49 | -2.6% | 1,017,800 |
1301~
1350
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「住友ファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
住友ファーマ | 78,300円 | -11.0% | +206.6% | 0.00% | 7.78倍 | 1.84倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ロート | 204,000円 | +8.4% | +0.2% | 2.06% | 14.83倍 | 1.78倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 415,400円 | +5.8% | +1.2% | 2.89% | 13.78倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 349,600円 | +3.8% | -19.9% | 3.89% | 11.44倍 | 0.88倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 345,300円 | +8.0% | -15.3% | 3.59% | 9.69倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム